Theriva Biologics, Inc.
TOVX · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3 | $3 | $2 |
| - Cash | $8 | $12 | $10 | $12 |
| + Debt | $2 | $1 | $3 | $2 |
| Enterprise Value | – | -$8 | -$4 | -$8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$13 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$13 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.45 | -1.93 | -1.55 | -1.6 |
| % Growth | 76.7% | -24.5% | 3.1% | – |
| Operating Cash Flow | -$4 | -$5 | -$5 | -$5 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$4 | -$5 | -$5 | -$5 |